☰

Zhiping Mi - Publications

Affiliations: 
2004-2010 Child Neurology University of Pittsburgh Medical School, PA 15232 USA 
Tree Info Grants Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Qazi A, Halterman MW, Mi Z, Zhang T, Schor NF. Chopper is prodeath regardless of the effect of p75ICD on sensitivity to oxidative stress. Oxidative Medicine and Cellular Longevity. 2011: 391659. PMID 21904642 DOI: 10.1155/2011/391659  0.49
2009 Zhang T, Mi Z, Schor NF. Role of tyrosine phosphorylation in the antioxidant effects of the p75 neurotrophin receptor. Oxidative Medicine and Cellular Longevity. 2: 238-46. PMID 20716910 DOI: 10.4161/oxim.2.4.9745  0.523
2009 Mi Z, Rogers DA, Mirnics ZK, Schor NF. p75NTR-dependent modulation of cellular handling of reactive oxygen species. Journal of Neurochemistry. 110: 295-306. PMID 19457114 DOI: 10.1111/j.1471-4159.2009.06137.x  0.549
2008 Rogers D, Nylander KD, Mi Z, Hu T, Schor NF. Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy. Cancer Chemotherapy and Pharmacology. 62: 699-706. PMID 18338171 DOI: 10.1007/S00280-008-0725-7  0.442
2007 Korade Z, Mi Z, Portugal C, Schor NF. Expression and p75 neurotrophin receptor dependence of cholesterol synthetic enzymes in adult mouse brain. Neurobiology of Aging. 28: 1522-31. PMID 16887237 DOI: 10.1016/J.Neurobiolaging.2006.06.026  0.465
2006 Mi Z, Mirnics ZK, Schor NF. Bcl-2 overexpression disrupts the morphology of PC12 cells through reduced ERK activation. Brain Research. 1112: 46-55. PMID 16914120 DOI: 10.1016/J.Brainres.2006.07.017  0.547
2006 Mi Z, Hong B, Mirnics ZK, Tyurina YY, Kagan VE, Liang Y, Schor NF. Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2. Cancer Chemotherapy and Pharmacology. 57: 357-67. PMID 16001169 DOI: 10.1007/S00280-005-0054-Z  0.489
Show low-probability matches.